Median Technologies: Financial Communications Schedule for the First Half of 2024
22 Gennaio 2024 - 5:45PM
Business Wire
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible),
announces the publication date for its 2023 results:
Publication
Date
2023 results
April 25, 2024*
*Distribution after the close of trading
About Median Technologies: Pioneering in innovative imaging
solutions and services, Median Technologies harnesses cutting-edge
AI to elevate the accuracy of early cancer and metabolic disease
diagnoses and treatments. Median's offerings, including iCRO for
medical image analysis and management in oncology trials and
eyonis™, AI/ML tech-based suite of software as medical devices
(SaMD), empower biopharmaceutical entities and clinicians to
advance patient care and expedite novel therapies. Since its
inception, the French-based company, with a presence in the U.S.
and China, has been recognized as an "Innovative company" by BPI
France and trades on the Euronext Growth market (ISIN:
FR0011049824, ticker: ALMDT). Median is eligible for the French SME
equity savings plan scheme (PEA-PME). For more information:
www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240122056976/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ggasparetto@actifin.fr
Grafico Azioni Median Technologies (EU:ALMDT)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Median Technologies (EU:ALMDT)
Storico
Da Nov 2023 a Nov 2024
